位置:成果数据库 > 期刊 > 期刊详情页
Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection
  • ISSN号:1007-9327
  • 期刊名称:《世界胃肠病学杂志:英文版》
  • 时间:0
  • 分类:R735.7[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]Department of General Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071
  • 相关基金:by National Science Funds, No. 30471689
中文摘要:

瞄准:在兔子和细胞 p53/c-Myc 蛋白质表示在植入的肝的 VX2 肿瘤生长的抑制上由静脉注射评估羟磷灰石 nano 粒子(Nano 幸运) 的效果。方法:60 只肝的 VX2 忍受肿瘤的兔子随机被划分成五个组。Nano 幸运溶胶 20 mg/kg, 40 mg/kg, 5-FU 答案 20 mg/mL, 5-FU 答案 20 mg/mL 的混合白酒和 Nano 幸运溶胶 20 mg/kg 被静脉灌输,作为控制进行的生理盐水。一般状态,重量,肝函数和粗野肿瘤体积动态地被检测。在肿瘤织物的 p53 和 c-Myc 基因蛋白质的表示被免疫组织化学方法检测。结果:植入的肝的 VX2 肿瘤的生长显著地在所有治疗组,被禁止在注射以后的 3 wk,肿瘤控制在 Nano 幸运溶胶组评价分别地是 25.5% 和 32.5% ,并且粗野肿瘤体积显然是不到控制的组。(24.81 +/- 5.17 和 22.73 +/- 4.23 对 33.32 +/- 5.26, P 【 0.05 ) 。5-FU 组的肿瘤控制率是 43.7%(18.74 +/- 4.40 对 33.32 +/- 5.26, P 【 0.05 ) ,但是在注射以后的动物的一般状态加重了;并且在药联合组的不利反应显然减少了。由于 Nano 幸运的效果,肿瘤的积极表达式联系了变异的 p53,在肿瘤织物的 c-Myc 与控制组相比显然被减少。结论:Nano 幸运在兔子上有明显的禁止的行动植入的肝的 VX2 肿瘤在活体内,它可以是减少的结果变异的 p53 和 c-myc 的表示,和药联合罐头显然减少 5-FU 的不利反应。

英文摘要:

AIM: To evaluate the effect of hydroxyapatite nano- particles (Nano HAP) by intravenous injection on the inhibition of implanted hepatic VX2 tumor growth in rabbits and cell p53/c-Myc protein expression. METHODS: 60 hepatic VX2 tumor-bearing rabbits was randomly divided into five groups. Nano HAP collosol 20 mglkg, 40 mg/kg, 5-FU solutions 20 mg/mL, mixed liquor of 5-FU solution 20 mg/mL and Nano HAP collosol 20 mg/kg were infused by vein, normal saline conducted as the control. The general state, weight, liver function and gross tumor volume were detected dynamically. The expression of p53 and c-Myc gene protein in tumor tissue was detected by immunohistochemistry methods. RESULTS: The growth of implanted hepatic VX2 tumors was significantly inhibited in all therapy groups, 3 wk after the injection, the tumor control rates in Nano HAP collosol groups were 25.5% and 32.5% respectively, and the gross tumor volumes were obviously less than that of control group. (24.81 ± 5.17 and 22.73 ± 4.23 vs 33.32 ± 5.26, P 〈 0.05). The tumor control rate of 5-FU group was 43.7% (18.74 4± 4.40 vs 33.32 ± 5.26, P 〈 0.05), but the general state of the animals after injection aggravated; and the adverse reaction in the drug combination group obviously decreased. Due to the effect of Nano HAP, the positive expression of tumor associated the mutated p53 and c-Myc in tumor tissue was decreased obviously compared with the control group. CONCLUSION: Nano HAP has evident inhibitory action on rabbit implanted hepatic VX2 tumor in vivo, which may be the result of decreasing the expression of the mutated p53 and c-myc, and drug combination can obviously decrease the adverse reaction of 5-FU.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《世界胃肠病学杂志:英文版》
  • 主管单位:
  • 主办单位:百世登出版集团有限公司
  • 主编:
  • 地址:太原双塔西街77号
  • 邮编:100023
  • 邮箱:
  • 电话:0351-4078656
  • 国际标准刊号:ISSN:1007-9327
  • 国内统一刊号:ISSN:
  • 邮发代号:
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,荷兰文摘与引文数据库,荷兰医学文摘,美国生物医学检索系统,美国科学引文索引(扩展库),日本日本科学技术振兴机构数据库,瑞典开放获取期刊指南
  • 被引量:12408